Research Topics
| T L SkaerSummaryAffiliation: Washington State University Country: USA Publications
|
Detail Information
Publications
The need for an iterative process for assessing economic outcomes associated with SSRIsT L Skaer
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman, Washington, USA
Pharmacoeconomics 18:205-14. 2000..The portfolio of evidence to date indicates that the first-line use of SSRIs in the treatment of depression is clinically warranted, and represents value for money...- Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997T L Skaer
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman 99164 6510, USA
Clin Ther 22:1575-89. 2000.... - Practice guidelines for transdermal opioids in malignant painTracy L Skaer
Pharmacoeconomics and Pharmacoepidemiology Research Unit, Washington State University, Pullman, Washington 99164 6510, USA
Drugs 64:2629-38. 2004.... - Economic appraisal of citalopram in the management of single-episode depressionD A Sclar
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman 99164 6510, USA
J Clin Psychopharmacol 19:47S-54S. 1999..Multivariate models adjusted for nonrandom assignment to the initial pharmacotherapeutic option confirmed these findings. Further research over a longer time course is warranted... - Economic appraisal of antidepressant pharmacotherapy: critical review of the literature and future directionsD A Sclar
College of Pharmacy, Washington State University, Pullman 99164 6510, USA
Depress Anxiety 8:121-7. 1998..Herein, we review the pharmacoeconomic literature relative to antidepressant pharmacotherapy and identify issues for future inquiry... 
Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?David A Sclar
Pharmacoeconomics and Pharmacoepidemiology Research Unit, Department of Health Policy and Administration, Washington State University, P O Box 646510, Pullman, WA 99164 6510, USA
Gen Hosp Psychiatry 30:73-6. 2008..private) of U.S. patients aged 5-18 years who were hospitalized with a primary diagnosis of depression and (b) to discern the mean hospital length of stay and mean charge per day by payer type...- Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United StatesDavid A Sclar
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman, WA 99164 6510, USA
Int Clin Psychopharmacol 23:106-9. 2008..6 to 5.2 for blacks, and from 3.0 to 5.6 for Hispanics. It can be concluded that by 2003-2004, diagnostic and treatment rates were comparable among blacks and Hispanic, but were less than half the observed rates for whites... - Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visitsJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
Prim Care Diabetes 3:197-9. 2009..S. National Ambulatory Medical Care Survey (NAMCS). Our findings indicate a significant proportion of U.S. ambulatory patients with DM present with obesity and greater clinical acuity than patients with DM alone... - Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent PsychiaTracy L Skaer
Pharmacoeconomics and Pharmacoepidemiology Research Unit, Washington State University, Pullman, Washington 99164 6510, USA
Clin Ther 31:1478-87. 2009..Tricyclic antidepressants (TCAs) were not recommended because of insufficient efficacy evidence, as well as adverse events... - Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemiaMegan N Willson
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
Am J Cardiovasc Drugs 10:105-8. 2010..Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia... - Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?Tracy L Skaer
College of Pharmacy, Washington State University, PO Box 646510, Pullman, WA 99164 6510, USA
Diabetes Educ 32:940-53. 2006.... - Consumption of alcohol by sows in a choice testSylvie Cloutier
Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Center for the Study of Animal Well being, Washington State University, PO Box 646520, Pullman, WA 99164 6520, USA
Physiol Behav 88:101-7. 2006.... 
Transdermal opioids for cancer painTracy L Skaer
College of Pharmacy, Washington State University, Wegner Hall Room 105, PO Box 646510, Pullman, WA 99164 6510, USA
Health Qual Life Outcomes 4:24. 2006..Thus, buprenorphine may not be an appropriate medication for some patients with advanced unremitting cancer pain...- Datapoints: trends in ADHD and stimulant use among adults: 1995-2002Linda M Robison
Department of Health Policy and Administration, Washington State University, P.O. Box 646510, Pullman, Washington 99164-6510, USA
Psychiatr Serv 56:1497. 2005 - Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission David A Sclar
Department of Health Policy and Administration, Washington State University, Pullman, WA 99164 6510, USA
Drugs R D 6:149-56. 2005.... - Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99Linda M Robison
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman 99164 6510, USA
Int Clin Psychopharmacol 19:17-22. 2004..5% of those aged 5-8 years. The reasons for the gender and age group differences discerned in this study require further investigation, as does the reason why 15.1% of children were receiving no treatment beyond the office-based visit... - Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulantsLinda M Robison
Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, Pullman, Washington 99164 6510, USA
CNS Drugs 16:129-37. 2002.... - Economic implications of sleep disordersTracy L Skaer
Pharmacoeconomics and Pharmacoepidemiology Research Unit, Washington State University, Pullman, Washington, USA
Pharmacoeconomics 28:1015-23. 2010.... - The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal womenL R Fournier
Department of Psychology, Washington State University, Pullman, WA 99164 4820, USA
J Nutr Health Aging 11:155-64. 2007..Because of the health concerns related to hormone replacement therapy (HRT), alternative approaches to treat menopausal symptoms, such as nutritional supplements and/or diet containing isoflavones, are of interest... - Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndromeDavid A Sclar
Pharmacoeconomics and Pharmacoepidemiology Research Unit, Washington State University, Pullman, WA 99164 6510, USA
Headache 48:126-9. 2008..To discern the prevalence of concomitant use of a triptan and a selective serotonin reuptake inhibitor (SSRI) or a selective serotonin/norepinephrine reuptake inhibitor (SNRI) in the USA...